Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to -$0.98.

  • Cardio Diagnostics Holdings' EPS (Basic) rose 4335.26% to -$0.98 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.84, marking a year-over-year increase of 16232.66%. This contributed to the annual value of -$0.31 for FY2024, which is 5279.33% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its EPS (Basic) stood at -$0.98 for Q3 2025, which was up 4335.26% from -$0.97 recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' EPS (Basic) registered a high of -$0.06 during Q4 2024, and its lowest value of -$5.93 during Q1 2024.
  • Its 5-year average for EPS (Basic) is -$0.9, with a median of -$0.28 in 2022.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 8578.34% in 2023, then plummeted by 538264.31% in 2024.
  • Cardio Diagnostics Holdings' EPS (Basic) (Quarter) stood at -$0.12 in 2021, then tumbled by 518.55% to -$0.77 in 2022, then surged by 85.78% to -$0.11 in 2023, then soared by 48.4% to -$0.06 in 2024, then tumbled by 1634.66% to -$0.98 in 2025.
  • Its EPS (Basic) was -$0.98 in Q3 2025, compared to -$0.97 in Q2 2025 and -$0.97 in Q1 2025.